Monoclonal Antibodies Quality & Regulatory Requirements

Advanced training course covering monoclonal antibodies quality standards, regulatory compliance, process validation, analytical profiling, and lifecycle management for biologics and biosimilars.

The Monoclonal Antibodies Quality & Regulatory Requirements training course provides comprehensive insights into the evolving regulatory landscape and quality expectations for biologics and advanced monoclonal antibody products. The program focuses on critical topics including International Council for Harmonisation quality guidance, process characterisation, comparability protocols, Quality by Design (QbD), analytical product profiling, and lifecycle management strategies.

Participants will gain practical knowledge of process validation, BLA/MAA regulatory submissions, technology transfer, continuous process verification, and manufacturing control strategies for clinical and commercial biologics production. The course also addresses biosimilars, antibody-drug conjugates (ADCs), bispecific antibodies, stability challenges, and current industry trends through expert-led presentations, case studies, and interactive discussions.

Designed for professionals in quality assurance, regulatory affairs, analytical development, manufacturing, and CMC, this training delivers actionable regulatory and compliance strategies for the pharmaceutical and biotechnology industries.